medigraphic.com
Academia Mexicana de Neurología, A.C.

2010, Number 6

<< Back Next >>

Rev Mex Neuroci 2010; 11 (6)

Quality of life in patients with Parkinson’s disease

Martínez-Jurado E, Cervantes-Arriaga A, Rodríguez-Violante M

Language: Spanish
References: 48
Page: 480-486
PDF size: 149.79 Kb.


ABSTRACT

Parkinson’s disease (PD) is a disabling and progressive neurological disorder with diverse motor and nonmotor symptoms that affect patient’s functionality as well as their expectatives about their phscial, mental and social well being which in turn impactsdirectly on the quality of life. There is currently no cure for PD and therefore the objective of management is aimed at reducing symptoms and neutralizing their effects on quality of life. Clinical instruments have been developed in order to measure quality of life in patients with PD that allow us to comprehensively assess not only the clinical but also the effect of treatment and other interventions in their daily life activities. This paper describes the properties and characteristics of existing clinimetric instruments for assessing the quality of life of patients with PD, as well as the main factors determining it.


REFERENCES

  1. Lees AJ, Hardy J, Revesz T. Parkinson’s disease. Lancet 2009; 373: 2055-66.

  2. Murphy B, Herrman H, Hawthorne G, Pinzone T, EvertH. Australian WHOQoL instruments: User’s manual and interpretation guide. Australian WHOQoL Field Study Centre. World Health Organization 1993.

  3. Guyatt GH, Feeny DH, Patrick DL. Measuting health-related quality of life. Ann Intern Med 1993; 118: 622-9.

  4. Ware JE. Standards for validating health measures: definition and content. J Chronic Dis 1987; 40: 463-80.

  5. Martínez-Martín P, Cubo E. Calidad de vida en la enfermedad de Parkinson. In: Martínez-Martín P (ed.). Calidad de vida en neurología. Barcelona: Ars Medica; 2006, p. 203-20.

  6. Damiano AM, Snyder C, Strausser B, Willian MK. A review of healthrelated quality-of-life concepts and measures for Parkinson’s disease. Qual Life Res 1999; 8: 235-43.

  7. Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ. A comprehensive model of health-related quality of life in Parkinson’s disease. J Neurol 2008; 255: 1580-7.

  8. Goetz CG, Tilley BC, Shaftman SR, Stebbings GT, Fahn S, Martínez- Martin P, et al. Movement disorder society-sponosred revision of the Unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-70.

  9. Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. An international multicentre pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study, Mov Disord 2006; 21(7): 916-23.

  10. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of Life in Parkinson’s Disease: The Relative Importance of the Symptoms. Movt Disord 2008; 23: 1428-34.

  11. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30: 473-83.

  12. Marinus J, Ramaker C, van Hilten JJ, Stigellbout AM. Health related quality of life in Parkinson’s disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002; 72: 241-8.

  13. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures. J Neurol 1998; 245 (Suppl 1): 10-4.

  14. Hagell P, Nygren C. The 39 item Parkinson’s disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry 2007; 78: 1191-8.

  15. Souza R, Borges V, de Azovedo Silva SM, Ballalai Ferraz H. Quality of life scale in Parkinson’s disease. Arq Neuropsiquiatr 2007; 65: 787-91.

  16. Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson’s Disease, Vol. 2. Florham Park, NJ. Macmillan Health Care Information 1987, p. 15 3-163, 293-304.

  17. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson’s disease questionnaire. Psychol Health 1997; 12: 805-14.

  18. Boer AG, Wijker W, Speelman JD, de Haes JC. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996l; 61: 70-4.

  19. Schulzer M, Mak E, Calne SM. The psychometric properties of the Parkinson’s impact sclae (PIMS) as a measure of quality of life in Parkinson’s disease. Parkinsonism Rel Disord 2003; 9: 291-4.

  20. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G. Predictors and course of health-related quality of life in Parkinson’s disease. Mov Disord 2008; 23: 1420-7.

  21. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008; 70: 2241-7.

  22. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 2000; 69: 308-12.

  23. Stewart KC, Fernandez HH, Okun MS, Jacobson CE, Hass CJ. Distribution of motor impairment influences quality of life in Parkinson’s disease. Mov Disord 2008; 23: 1466-8.

  24. Gómez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, et al. Influence of motor symptoms upon the quality of life of patients with Parkinson’s disease. Eur Neurol 2007; 57: 161-5.

  25. Martínez-Martín P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007; 22: 1623-9.

  26. Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, Chan P. Health related quality of life in early Parkinson’s disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 2009: En prensa.

  27. Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z, et al. Impact of fatigue on quality of life in patients with Parkinson’s disease. Eur J Neurol 2008; 15: 475-80.

  28. Herlofson K, Larsen JP. The influence of fatigue on health-related quality of life in patients with Parkinson’s disease. Acta Neurol Scand 2003; 107: 1-6.

  29. Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson’s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 2004; 10: 129-36.

  30. Cersosimo MG, Benarroch EE. Neural Control of the Gastrointestinal Tract: Implications for Parkinson Disease. Mov Disord 2008; 23: 1065- 1075.

  31. Caap-Ahlgren M, Dehlin O. Insomnia and depressive symptoms in patients with Parkinson’s disease. Relationship to health-related quality of life. An interview study of patients living at home. Arch Gerontol Geriatr 2001; 32: 23-33.

  32. Hirayama MS, Gobbi S, Gobbi LT, Stella F. Quality of life (QoL) in relation to disease severity in Brazilian Parkinson’s patients as measured using the WHOQOL-BREF. Arch Gerontol Geriatr 2008; 46: 147-60.

  33. Slawek J, Derejko M, Lass P. Factors affecting the quality of life of patients with idiopathic Parkinson’s disease –a cross-sectional study in an outpatient clinic attendees. Parkinsonism Relat Disord 2005; 11: 465-8.

  34. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson’s disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 2000; 69: 584-9.

  35. Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson’s disease beyond its relationships with mobility and gait. Mov Disord 2007; 22: 2192-5.

  36. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Young-versus older-onset Parkinson’s disease: impact of disease and psychosocial consequences. Mov Disord 2003; 18: 1250-6.

  37. Behari M, Srivastava AK, Pandey RM. Quality of life in patients with Parkinson’s disease. Parkinsonism Relat Disord 2005; 11: 221-6.

  38. Leentjens AFG, Lousberg R, Verhey FJR. Markers for depression in Parkisnon’s disease. Acta Pyschatr Scand 2002; 106:196-201.

  39. Encarnacion EV, Hauser RA .Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments. Eur Neurol 2008; 60: 57-66.

  40. Martínez-Martín P, Deuschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Mov Disord 2007; 22: 757-65.

  41. Gallagher DA, Schrag A. Impact of newer pharmacological treatments on quality of life in patients with Parkinson’s disease. CNS Drugs 2008; 22: 563-86.

  42. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 2008; 23: 631-40.

  43. Simons G, Thompson SB, Smith Pasqualini MC. An innovative education programme for people with Parkinson’s disease and their careers. Parkinsonism Relat Disord 2006; 12: 478-85.

  44. Pacchetti C, Mancini F, Aglieri R, Fundaro C, Martignoni E, Nappi G. Active music therapy in Parkinson’s disease: an integrative method for motor and emotional rehabilitation. Psychosom Med 2000; 62: 386-93.

  45. Eng ML, Lyons KE, Greene MS, Pahwa R. Open-label trial regarding the use of acupuncture and yin tui na in Parkinson’s disease outpatients: a pilot study on efficacy, tolerability, and quality of life. J Altern Complement Med 2006; 12:395-9.

  46. Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, et al. Acupuncture therapy for the symptoms of Parkinson’s disease. Mov Disord 2002; 17:799-802.

  47. Dowding CH, Shenton CL, Salek SS. A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs Aging 2006; 23: 693-721.

  48. Cubo E, Martínez-Martín P, González M, Frades B. Impacto de los síntomas motores y no motores en los costes directos de la enfermedad de Parkinson. Neurología 2009; 24: 15-23.




2020     |     www.medigraphic.com